Expression of stem cell factor in the lesional skin of systemic sclerosis

Dermatology

Volumn 197, Issue 2, 1998, Pages 109-114

  Yamamoto, Toshiyuki ^a   Katayama, L ^a   Nishioka, K ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Mast cell; Scleroderma; Stem cell factor

Indexed keywords

INTERLEUKIN 3; MESSENGER RNA; STEM CELL FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MAST CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCLERODERMA; SKIN DEFECT; SKIN EDEMA; SPINDLE CELL;

EID: 0031827389     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017979     Document Type: Article

References (27)

1. Nishioka K. Kobayashi Y, Katayama I, Takijiri C: Mast cell numbers in diffuse scleroderma. Arch Dermatol 1987;123:205-208.
2. Hawkins RA, Claman HN, Clark RAF, Steigerwald JC: Increased dermal mast cell populations in progressive systemic sclerosis: A link in chronic fibrosis? Ann Intern Med 1985;102: 182-186.
3. T cells in the skin and evidence of mast cell activation. Arthritis Rheum 1992;35:933-939.
4. Coleman JW, Holliday MR, Kimber I, Zsebo KM, Galli SJ: Regulation of mouse peritoneal mast cell secretory function by stem cell factor, IL-3 or IL-4. J Immunol 1993;150:556-562.
5. Columbo M, Horowitz EM, Botana LM, MacGlashan DW Jr, Bochner BS, Gillis S, Zsebo KM, Galli SJ, Lichtenstein LM: The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral bloodbasophils. J Immunol 1992;149: 599-608.
6. Tsai M, Shih L, Newlands GFJ, Takeishi T, Langley KE, Zsebo KM, Miller HR, Geissler EN, Galli SJ: The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo: Analysis by anatomical distribution, histochemistry, and protease phenotype. J Exp Med 1991;174:125-131.
7. Meininger CJ, Yano H, Rottapel R, Bernstein A, Zsebo KM, Zetter BR: The c-kit receptor ligand functions as a mast cell chemoattractant. Blood 1992;79:958-962.
8. Longley BJ Jr, Morganroth GS, Tyrell BA, Ding TG, Anderson DM, Williams DE, Halaban R: Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. N Engl J Med 1993;328:1302-1307.
9. Hamann K, Haas N, Grabbe J, Czarnetzki BM: Expression of stem cell factor in cutaneous mastocytosis. Br J Dermatol 1995;133: 203-208.
10. Yamamoto T, Katayama I, Nishioka K: Impaired expression of stem cell factor in dermatofibroma fibroblast. Acta Derm Venereol (Stockh) 1996;76:257-259.
11. American Rheumatism Association: subcommittee for Scleroderma Criteria of the American Rheumatism Association Dignostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23: 581-590.
12. Yamamoto T, Katayama I, Nishioka K: Mast cell numbers in multiple dermatofibromas. Dermatology 1994;190:9-13.
13. Kischer CW, Bunce H, Shetlar MR: Mast cell analysis in hypertrophic scars, hypertrophic scars treated with pressure and mature scars. J Invest Dermatol 1978;70:355-357.
14. Rothe MJ, Kerdel FA: The mast cell in fibrosis. Int J Dermatol 1991;30:13-16.
15. Galli SJ: New concepts about the mast cell. N Engl J Med 1993;328:257-275.
16. Gordon JR, Galli SJ: Promotion of mouse fibroblast collagen gene expression by mast cells stimulated via the Fc ε R I: Role for mast cell-derived transforming growth factor β and tumor necrosis factor α. J Exp Med 1994;180: 2027-2037.
17. Gruber BL: Mast cells: Accessory cells which potentiate fibrosis. Int Rev Immunol 1995;12: 259-279.
18. Williams DE, Eisenman J, Baird A, Rauch C, Van Ness K, March CJ, Park LS, Martin U, Mochituki DY, Boswell HS, Burgess GS, Cosman D, Lyman SD: Identification of a ligand for the c-kit protooncogene. Cell 1990;63: 167-174.
19. Zsebo KM, Williams DA, Geissler EN, Broudy VC, Martin FH, Atkins HL, Hsu R-Y, Birkitt NC, Okino KH, Murdock DC, Jacobsen FW, Langley KE, Smith KA, Takeishi T, Cattanach BM, Galli SJ, Suggs SV: Stem cell factor (SCF) is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 1990;63:213-224.
20. Valent P, Spanblochl E, Sperr WR, Sillaber C, Zsebo KM, Agis H, Strobl H, Geissler K, Bettelheim P, Lechner K: Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit ligand in long-term culture. Blood 1992;80:2237-2242.
21. Grabbe J, Welker P, Dippel E, Czarnetzki BM: Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes. Arch Dermatol Res 1994;287:78-84.
22. Katayama I, Yokozeki H, Nishioka K: Induction and characterization of mast cell colonies by culture supernatants of retinoic acid-treated mouse keratinocytes. Int Arch Allergy Immunol 1993;100:328-332.
23. Morita E, Lee DG, Sugiyama M, Yamamoto S: Expression of c-kit ligand in human keratinocytes. Arch Dermatol Res 1994;286:273-277.
24. Weiss RR, Whitaker-Menezes D, Longley J, Bender J, Murphy GF: Human dermal endothelial cells express membrane-associated mast cell growth factor. J Invest Dermatol 1995;104:101-106.
25. Denton CP, Shi-wen X, Black CM, Pearson JD: Scleroderma fibroblasts show increased responsiveness to endothelial cell-derived IL-1 and bFGF. J Invest Dermatol 1997;108: 269-274.
26. Pope JE, Shum DT, Gottschalk R, Stevens A, Mcmanus R: Increased pigmentation in scleroderma. J Rheumatol 1996;23:1912-1916.
27. Costa JJ, Demetri GD, Harrist TJ, Dvorak AM, Hayes DF, Merica EA, Menchara DM, Gringeri AJ, Schwartz LB, Galli SJ: Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. J Exp Med 1996;183:2681-2686.